Found 5 articles for: "Extracellular Matrix"
Cardamonin Inhibits Keloid Fibroblast Activation and Extracellular Matrix Production Through Suppression of TGF-β1/Smad Signaling
September 2026 | Volume 25 | Issue 9 | Original Article | 857 | Copyright © September 2026
Background: Keloids are pathological scars characterized by persistent fibroblast activation and excessive extracellular matrix (ECM) deposition. Cardamonin (CARD), a natural cha...
Read MoreExtracellular Matrix Remodeling as a Driver of Skin Tightening and Skin Quality: TriHex+ and Device-Assisted Delivery
September 2026 | Volume 25 | Issue 9 | Features | e77 | Copyright © September 2026
The Dermoepidermal Junction as the Initiation Point for Reversal of Dermatoporosis
April 2026 | Volume 25 | Issue 4 | Original Article | 377 | Copyright © April 2026
Background: Dermatoporosis (DP) or chronic cutaneous fragility syndrome has traditionally been linked to extracellular matrix (ECM) dehydration, reduced cellular turnover, epider...
Read MoreTransitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity
March 2026 | Volume 25 | Issue 3 | Original Article | 268 | Copyright © March 2026
Background: Skin thinning, known as dermatoporosis, is an expected consequence of aging that involves structural weaknesses, barrier deficiencies, and cellular senescence, posing...
Read MoreWATCH VIDEO ABSTRACT: Dermatoporosis: Strategies for Rebuilding the Extracellular Matrix of the Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 861 | Copyright © September 2023
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
